Ondrey Aaron 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Apr 8, 2025
Insider Transaction Report
Form 4
Ondrey Aaron
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-04-04$5.29/sh−7,489$39,647→ 129,650 total
Footnotes (2)
- [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
- [F2]The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.